Histopathological examination confirmed invasive ductal carcinoma, grade 2, with positive expression of ER and progesterone (PR), HER2 negativity (score 0), and a Ki67 index of 50%. The gene discussed is ERBB2; the disease is invasive ductal breast carcinoma.